Why chronic inflammation quietly undermines every health goal

Recovery that used to take a day now takes three. Joints that feel fine at rest announce themselves after a long week. Energy that once returned overnight seems to need the whole weekend. These are not random signs of getting older — they may be signals of something operating silently at the cellular level: chronic low-grade inflammation, or what researchers now call inflammaging.

Acute inflammation is the body doing its job — swelling around a sprain, heat around an infection. It arrives, it resolves, it repairs. Inflammaging is the opposite: a persistent, low-intensity fire that never fully extinguishes. Over years, it undermines cellular repair, slows recovery, erodes energy, and accelerates biological ageing. Research increasingly identifies it as a common thread running through cardiovascular decline, immune dysregulation, and the kind of joint and metabolic changes that accumulate quietly through middle age.

In Professor Paul Lee's framework, set out in Regeneration by Design, this is precisely the terrain of the Chemistry pillar — the body's internal environment, which is not fixed by genetics or luck but is something an informed person can actively influence. The question worth asking is not simply what to take, but how omega-3, curcumin and ginger actually intervene at the cellular level — and whether the mechanisms make them genuinely complementary.

Omega-3s: from blocking inflammation to actively resolving it

Most people think of anti-inflammatory nutrients as brakes — things that slow down a process. Omega-3 fatty acids do that, but they also do something structurally different, and the distinction matters.

Stage one: starving the fire of its fuel

When EPA and DHA — the long-chain omega-3s found in oily fish and quality supplements — are consumed consistently, they gradually integrate into cell membranes, displacing arachidonic acid, the omega-6 fatty acid that acts as the primary raw material for pro-inflammatory signalling. Think of it as a car park with limited spaces: if EPA and DHA occupy them, arachidonic acid cannot get a place. The COX and LOX enzymes that would normally convert it into pro-inflammatory prostaglandins and leukotrienes are left without their substrate. Output falls. The brakes are real.

Omega-3s also bind a cell-surface receptor called GPR120, which delivers a further intracellular signalling brake — a separate route to dampening inflammatory activation.

Stage two: active resolution

This is where omega-3s depart entirely from the NSAID model. Rather than simply suppressing inflammation, enzymes convert EPA into E-series resolvins (RvE1 and RvE2) and DHA into D-series resolvins, protectins, and maresins — collectively termed Specialised Pro-Resolving Mediators, or SPMs. These are not inhibitors; they are instructors. Operating at nanomolar-to-picomolar concentrations, SPMs direct neutrophils to stop infiltrating tissue, prompt macrophages to clear cellular debris — a process called efferocytosis — and signal repair pathways to begin. Resolution is an active clean-up operation, not the mere absence of fire.

A 2025 systematic review found that inflammatory conditions correlate with depleted omega-3-derived SPMs, and that supplementation may help restore this balance and reduce inflammatory markers. The underlying science is compelling; large long-term RCTs focused specifically on SPM endpoints are still accumulating, so precise clinical translation remains a work in progress.

Curcumin: switching off the master inflammatory gene regulator

Buried inside almost every cell is a protein complex called NF-κB — a transcription factor that functions like a master conductor for inflammation. When activated, it simultaneously switches on hundreds of pro-inflammatory genes, flooding the body's internal environment with cytokines, adhesion molecules, and enzyme signals. Curcumin, the principal polyphenol of turmeric (Curcuma longa), inhibits NF-κB activation directly — not just one downstream product, but the upstream switch itself. It also blocks COX-2 and 5-LOX enzymes, reducing the same prostaglandin and leukotriene output that omega-3s address by substrate competition. Two distinct routes converging on the same inflammatory cascade.

A second mechanism: switching on the antioxidants

Curcumin's other major action operates in a different register entirely. It activates Nrf2 (NFE2L2), a transcription factor that drives the body's own production of antioxidant enzymes — including haem oxygenase-1 (HO-1) and superoxide dismutase (SOD). This matters because oxidative stress and inflammation form a self-reinforcing loop: reactive oxygen species provoke inflammatory signalling, which generates more oxidative stress. Nrf2 activation interrupts that cycle at source, rather than just patching the downstream damage.

The bioavailability problem — and what to do about it

Here is the practical caveat that most coverage glosses over: over 90% of oral curcumin is excreted unabsorbed. Standard turmeric supplements, and certainly culinary turmeric in food, are unlikely to deliver meaningful systemic concentrations. The compound is poorly absorbed, rapidly metabolised, and quickly cleared. An impressive mechanism profile counts for little if the molecule cannot reach its targets.

The well-established solution is co-supplementation with piperine — the active compound in black pepper. Piperine significantly inhibits curcumin's rapid clearance, markedly increasing bioavailability. This is not an optional refinement; it is a prerequisite for efficacy. The evidence base supporting this combination is now the strongest of the three nutrients reviewed here: a 2026 systematic review of 20 RCTs found that curcumin-piperine supplementation produced significant reductions in CRP, hs-CRP, and IL-6 in 15 of 20 trials, and improved oxidative-stress markers in 12 of 15 studies. When choosing a curcumin supplement, formulations that include 5–20 mg of piperine — or that use alternative enhanced-absorption technologies — should be the baseline expectation, not a premium extra.

Ginger: NSAID-like effects without the pharmaceutical trade-offs

For anyone who reaches for ibuprofen after a long run or a stiff morning, ginger offers an instructive comparison. Its active compounds inhibit both COX and LOX enzymes — the same enzymatic targets as non-steroidal anti-inflammatory drugs — but through a different cellular mechanism, and without the gastrointestinal or cardiovascular trade-offs associated with long-term pharmaceutical NSAID use. The comparison is mechanistic, not a basis for self-substitution; ginger is a dietary compound with a distinct dose-and-bioavailability profile, not a drug.

6-gingerol and 6-shogaol: why preparation matters

Fresh ginger's primary bioactive phenol, 6-gingerol, blocks COX-2 expression by inhibiting P38 MAP kinase — a signalling enzyme that relays inflammatory stress signals — and simultaneously suppresses NF-κB, the same master transcription factor curcumin targets. A third route runs through Akt signalling: by inhibiting Akt, 6-gingerol shifts the cytokine balance away from pro-inflammatory output (TNF-α, IL-1β, IL-6) and towards anti-inflammatory signals.

When ginger is dried or heated, 6-gingerol converts to 6-shogaol. This is a practically useful distinction: the two molecules are not interchangeable. 6-Shogaol retains the NF-κB and MAPK inhibitory actions but adds suppression of inducible nitric oxide synthase (iNOS) and broader MAPK modulation — a slightly wider mechanistic footprint than the fresh form.

Early evidence for combination use

A 2024 in vivo study administered ginger extract and omega-3 fatty acids separately and together in a cardiac inflammation model. The combination produced additive reductions in NF-κB, TNF-α, IL-6, and lipid peroxidation, while raising Nrf2 and antioxidant enzyme levels beyond either agent alone. This is early mechanistic evidence — animal data — but it supports the biological rationale for pairing ginger with the other two compounds rather than treating them as alternatives.

One honest caveat: gingerol bioavailability is limited, and nanoformulation delivery strategies are under active investigation. That work is currently research-stage and not yet standard in commercial supplements.

Where all three converge — and what each uniquely adds

Three different compounds, three distinct upstream routes — and yet all three arrive at the same destination: NF-κB. That convergence is not coincidental; it is the mechanistic logic that makes combining them coherent rather than redundant. Blocking the same master switch via independent pathways reduces the chance that inflammation simply reroutes around a single intervention.

The more revealing picture, though, emerges when you look past the shared node at what each agent uniquely contributes. Omega-3s are the only members of the three that actively generate Specialised Pro-Resolving Mediators — resolvins, protectins, and maresins — compounds that do not merely suppress inflammation but physically orchestrate its conclusion: clearing cellular debris, restoring tissue architecture, standing down the immune response. Neither curcumin nor ginger produces SPMs. Curcumin's distinct addition is Nrf2 activation — a self-amplifying antioxidant programme that breaks the oxidative-stress/inflammation loop from the inside, a mechanism the other two do not directly trigger. Ginger's singular contribution is Akt and P38 MAPK modulation — a cytokine-balancing route that operates at a different signalling layer from omega-3's membrane-level substrate competition and curcumin's transcription-factor focus.

Mapped onto the inflammatory cascade, the three agents address distinct stages: initiation (enzyme inhibition, substrate starvation), amplification (NF-κB suppression, cytokine dampening), and resolution (SPM-driven clearance and tissue repair). That is a fuller architecture of coverage than any single agent provides alone.

In Regeneration by Design, Professor Paul Lee frames the Chemistry pillar around precisely this recognition — that inflammation is a systemic process sustained by multiple reinforcing loops, not a single target to neutralise. Addressing it well means working across those loops simultaneously.

Putting it into practice: what this means for your Chemistry pillar

Science only earns its place at the table when it changes what you actually do. For these three compounds, the practical translation is straightforward — but the details matter.

Omega-3. Prioritise EPA and DHA from marine sources: oily fish two to three times a week, or a quality fish-oil or algal-oil supplement. The resolution biology — the SPM cascade described above — requires these two fatty acids specifically. Plant-based ALA from flaxseed or walnuts converts to EPA and DHA too poorly to replicate the effect.

Curcumin. Choose a piperine-enhanced formulation. Dietary turmeric is nutritionally worthwhile, but the quantities in cooking are unlikely to deliver meaningful systemic exposure when more than 90% of unenhanced curcumin is excreted unabsorbed. The 2026 systematic review showing CRP and IL-6 reductions across 75% of trials used piperine co-supplementation — that is the combination the evidence actually supports.

Ginger. Use both forms: fresh ginger for 6-gingerol, dried or cooked ginger for 6-shogaol. Culinary use is realistic at meaningful doses — the two molecular profiles are not interchangeable, and using both is a simple way to cover the full mechanistic footprint without straying into supplementation territory.

The 2024 combination data suggest these agents are additive rather than competitive, which supports treating them as a coherent nutritional environment rather than isolated supplements. That framing aligns with what Professor Paul Lee sets out in Regeneration by Design: Chemistry is one interdependent pillar, not a standalone fix. Omega-3s, curcumin, and ginger compound with what Physics (movement, load) demands of tissue and what Biology (gut health, sleep) determines about nutrient absorption and inflammatory baseline.

For those who want to track whether their nutritional choices are shifting the needle, baseline inflammatory markers — CRP, omega-3 index, where available — offer an objective reference point. The Regen PhD approach treats that kind of monitoring as part of the system.

The information here is general wellness education, not personalised medical advice. If you have a diagnosed inflammatory condition or take prescribed medication, speak with your healthcare professional before making changes to supplementation.